2009
DOI: 10.1017/s0022215109992507
|View full text |Cite
|
Sign up to set email alerts
|

Oral voriconazole for invasive fungal skull base infection

Abstract: Background: Intravenous amphotericin or intravenous voriconazole, both followed by oral voriconazole, have previously been given to treat invasive aspergillosis of the skull base.Case report: Exclusively oral voriconazole was used in an immunocompetent patient with biopsy-proven, invasive aspergillosis. She had a large, erosive lesion extending from the central skull base to the right orbit and ethmoid sinus, and displacing the right internal carotid artery. After four months of oral treatment as an out-patien… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 14 publications
(28 reference statements)
0
6
0
Order By: Relevance
“…Recommendations have ranged from medical management alone to radical surgery with adjuvant chemotherapy (4, 27, 28, 35). Combination antifungal therapy with amphotericin B and itraconazole, voriconazole, or micafungin with or without surgical intervention has been used successfully to control the infection in some cases (3, 19, 26, 28, 34, 35). Voriconazole recently has become the drug of choice for invasive aspergillosis because patients demonstrate a better tolerance for it and because of its lower toxicity compared with amphoterecin B (3); the overall response rate to antifungal chemotherapy ranges from 40% to 60% (39).…”
Section: Discussionmentioning
confidence: 99%
“…Recommendations have ranged from medical management alone to radical surgery with adjuvant chemotherapy (4, 27, 28, 35). Combination antifungal therapy with amphotericin B and itraconazole, voriconazole, or micafungin with or without surgical intervention has been used successfully to control the infection in some cases (3, 19, 26, 28, 34, 35). Voriconazole recently has become the drug of choice for invasive aspergillosis because patients demonstrate a better tolerance for it and because of its lower toxicity compared with amphoterecin B (3); the overall response rate to antifungal chemotherapy ranges from 40% to 60% (39).…”
Section: Discussionmentioning
confidence: 99%
“…Management of invasive sino-orbital Aspergillosis in immunocompetent patients remains controversial. Management modality ranges from medical management 12,13 alone to radical surgery with adjuvant chemotherapy. Combination of antifungal agents has been used successfully 14,15 to control infection in some studies.…”
Section: Discussionmentioning
confidence: 99%
“…Parize et al described a series of patients with Aspergillus necrotising otitis externa who were successfully treated with extensive surgical debridement and voriconazole 19 . Other reports include a case of nasocerebral aspergillosis that was successfully treated with voriconazole and steroids without the need for surgery, 20 and a case of invasive rhinogenic skull base disease managed with oral voriconazole alone with substantial cost savings 21 . Although our patient clinically suffered from petrous apicitis, we successfully treated him without recourse to apicectomy, and the cerebral abscess resolved with voriconazole therapy.…”
Section: Discussionmentioning
confidence: 99%